Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?8.20
 
WKN: A2DJWX / Symbol: CTIC / Name: CTi Biopharma / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Cti Biopharma Corp Stock

With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Cti Biopharma Corp stock is not clear.
On the other hand, the target price of 8 € is below the current price of 8.35 € for Cti Biopharma Corp, so the potential is actually -4.21%.

Pros and Cons of Cti Biopharma Corp in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cti Biopharma Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cti Biopharma Corp - - - - - - -
Larimar Therapeutics Inc. -2.500% 2.344% -17.610% 53.037% 54.481% -54.828% -
Vaxart Inc. -7.590% -18.135% -26.306% 25.040% 53.220% -82.323% -
Jaguar Health Inc. -7.450% 67.068% 160.000% 112.788% 10.199% -99.931% -

Comments

Prediction Buy
Perf. (%) 81.37%
Target price 8.196
Change
Ends at 20.04.24

CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 83.36%
Target price 8.416
Change
Ends at 06.03.24

CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
Show more

Buy Cti Biopharma Corp
Show more